163734-89-2 Usage
Molecular Structure
1H-Indole-3-acetic acid, 2-bromo-5-methoxy-1-(phenylmethyl)-, phenylmethyl ester is a chemical compound with a modified indole-3-acetic acid structure, which includes a bromine atom, a methoxy group, and a phenylmethyl ester.
Derivative of Hormone
It is a derivative of the hormone indole-3-acetic acid, which is involved in plant growth and development.
Modification of Chemical Structure
The addition of a bromine and methoxy group, as well as a phenylmethyl ester, modifies the chemical structure and potentially enhances its biological activity.
Increased Lipophilicity
The presence of the phenylmethyl ester increases the compound's lipophilicity, which may improve its cellular uptake and distribution.
Potential Pharmaceutical Applications
1H-Indole-3-acetic acid, 2-bromo-5-methoxy-1-(phenylmethyl)-, phenylmethyl ester may have potential applications in the field of medicine due to its modified structure and enhanced biological activity.
Potential Agricultural Applications
It may also have potential applications in agriculture, particularly in the development of new crop improvement strategies, as it is derived from a hormone involved in plant growth and development.
Check Digit Verification of cas no
The CAS Registry Mumber 163734-89-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,7,3 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 163734-89:
(8*1)+(7*6)+(6*3)+(5*7)+(4*3)+(3*4)+(2*8)+(1*9)=152
152 % 10 = 2
So 163734-89-2 is a valid CAS Registry Number.
163734-89-2Relevant articles and documents
1H-INDOLE-3-ACETAMIDE SPLA2 INHIBITORS
-
, (2008/06/13)
A class of novel 1-indole-3-acetamides represented by the formula; is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids.
1H-INDOLE-3-ACETIC ACID HYDRAZIDE SPLA2 INHIBITORS
-
, (2008/06/13)
A class of novel 1H-indole-3-acetic acid hydrazides is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids (e.g., arachidonic acid) for treatment of conditions such as septic shock
